View Item 

Show simple item record

Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes

dc.contributor.authorWu, A.en_US
dc.contributor.authorKunju, Lakshmi Pen_US
dc.contributor.authorCheng, L.en_US
dc.contributor.authorShah, Rajal B.en_US
dc.date.accessioned2010-06-01T21:43:20Z
dc.date.available2010-06-01T21:43:20Z
dc.date.issued2008-11en_US
dc.identifier.citationWu, A; Kunju, L P; Cheng, L; Shah, R B (2008). "Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes." Histopathology 53(5): 533-544. <http://hdl.handle.net/2027.42/74766>en_US
dc.identifier.issn0309-0167en_US
dc.identifier.issn1365-2559en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74766
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18983462&dopt=citationen_US
dc.format.extent1096178 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2008 Blackwell Publishing Ltden_US
dc.subject.otherRenal Cell Carcinoma in Children and Young Adultsen_US
dc.subject.otherTFE3en_US
dc.subject.otherXp11.2 Translocation-associated Renal Cell Carcinomaen_US
dc.titleRenal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUrology, University of Michigan School of Medicine, Ann Arbor, MIen_US
dc.contributor.affiliationotherDepartments of Pathologyen_US
dc.contributor.affiliationotherDepartment of Pathology, Indiana University School of Medicine, Indianapolis, IN, USAen_US
dc.identifier.pmid18983462en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74766/1/j.1365-2559.2008.03151.x.pdf
dc.identifier.doi10.1111/j.1365-2559.2008.03151.xen_US
dc.identifier.sourceHistopathologyen_US
dc.identifier.citedreferenceCarcao M, Taylor G, Greenberg M et al. Renal-cell carcinoma in children: a different disorder from its adult counterpart? Med. Pediatr. Oncol. 1998; 31; 152 – 158.en_US
dc.identifier.citedreferenceBruder E, Passera O, Harms D et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004; 28; 1117 – 1132.en_US
dc.identifier.citedreferenceMurphy WM, Grignon DJ, Perlman EJ eds. Tumors of the kidney, bladder and related urinary structures. Washington, DC: American Registry of Pathology, 2004.en_US
dc.identifier.citedreferenceEble JN, Sauter G, Epstein JI, Sesterhenn IA eds. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004.en_US
dc.identifier.citedreferenceEstrada C, Suthar A, Eaton S, Cilento B. Renal cell carcinoma: children’s hospital Boston experience. Urology 2005; 66; 1296 – 1300.en_US
dc.identifier.citedreferenceLack E, Cassady R, Sallan S. Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J. Urol. 1985; 133; 822 – 828.en_US
dc.identifier.citedreferenceGeller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 2004; 101; 1575 – 1583.en_US
dc.identifier.citedreferenceGeller JI, Argani P, Adeniran A et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer 2008; 112; 1607 – 1616.en_US
dc.identifier.citedreferenceArgani P, Ladanyi M. Translocation carcinomas of the kidney. Clin. Lab. Med. 2005; 25; 363 – 378.en_US
dc.identifier.citedreferenceArgani P, Antonescu CR, Couturier J et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 2002; 26; 1553 – 1566.en_US
dc.identifier.citedreferenceArgani P, Antonescu CR, Illei PB et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. Am. J. Pathol. 2001; 159; 179 – 192.en_US
dc.identifier.citedreferenceArgani P, Lal P, Hutchinson B, Lui MY, Reuter V, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. Am. J. Pathol. 2003; 27; 750 – 751.en_US
dc.identifier.citedreferenceSelle B, Furtwangler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population-based study of renal cell carcinoma in children in Germany, 1980-2005. Cancer 2006; 107; 2906 – 2914.en_US
dc.identifier.citedreferenceIndolfi P, Terenziani M, Casle F et al. Renal cell carcinoma in children: a clinicopathologic study. J. Clin. Oncol. 2003; 21; 530 – 535.en_US
dc.identifier.citedreferenceGeller JI, Khoury J, Dome J. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Author’s reply [letter]. Cancer 2005; 103; 1318.en_US
dc.identifier.citedreferenceFuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982; 6; 655 – 663.en_US
dc.identifier.citedreferenceArgani P, Ladanyi M. The evolving story of renal translocation carcinomas. Am. J. Clin. Pathol. 2006; 126; 332 – 334.en_US
dc.identifier.citedreferenceGreene FL, Page DL, Fleming ID et al. eds. AJCC cancer staging manual. New York, NY: Springer, 2002.en_US
dc.identifier.citedreferenceOosterwijk E, Bander NH, Divgi C et al. Antibody localization in human renal cell carcinoma: a Phase I study of monoclonal antibody G250. J. Clin. Oncol. 1993; 11; 738 – 750.en_US
dc.identifier.citedreferenceOosterwijk E, Ruiter D, Hoedemaeker P et al. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int. J. Cancer 1986; 38; 489 – 494.en_US
dc.identifier.citedreferenceIvanov S, Liao S-Y, Ivanova A et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol. 2001; 158; 905 – 919.en_US
dc.identifier.citedreferenceGobbo S, Eble JN, Grignon DJ et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am. J. Surg. Pathol. 2008; 32; 1239 – 1245.en_US
dc.identifier.citedreferenceKunju LP, Wojno K, Wolf JS, Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical, and molecular features. Hum. Pathol. 2008; 39; 96 – 101.en_US
dc.identifier.citedreferenceArgani P, Lui MY, Couturier J, Bouvier R, Fournet J-C, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003; 22; 5374 – 5378.en_US
dc.identifier.citedreferenceHuang F, Zwerdling T, Stern L, Ballard E, Warner B. Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. J. Pediatr. Hematol./Oncol. 2001; 23; 609 – 611.en_US
dc.identifier.citedreferenceArgani P, Lae M, Ballard E et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J. Clin. Oncol. 2006; 24; 1529 – 1534.en_US
dc.identifier.citedreferenceRamphal R, Pappo A, Zielenska M, Grant R, Ngan B-Y. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am. J. Clin. Pathol. 2006; 126; 349 – 364.en_US
dc.identifier.citedreferenceRais-Bahrami S, Drabick JJ, De Marzo A et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology 2007; 70; 178.e173 – 176.en_US
dc.identifier.citedreferenceGelb AB, Shibuya RB, Weiss LM, Medeiros LJ. Stage I renal cell carcinoma: a clinicopathologic study of 82 cases. Am. J. Surg. Pathol. 1993; 17; 275 – 286.en_US
dc.identifier.citedreferenceArgani P, Olgac S, Tickoo S et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 2007; 31; 1149 – 1160.en_US
dc.identifier.citedreferenceMeyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol. 2007; 128; 70 – 79.en_US
dc.identifier.citedreferenceAltinok G, Kattar M, Mohamed A, Poulik J, Grignon D, Rabah R. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr. Dev. Pathol. 2005; 8; 168 – 180.en_US
dc.identifier.citedreferenceAronson D, Medary I, Finlay J, Herr H, Exelby P, La Quaglia M. Renal cell carcinoma in childhood and adolescence: retrospective survey for prognostic factors in 22 cases. J. Pediatr. Surg. 1996; 31; 183 – 186.en_US
dc.identifier.citedreferenceDal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van den Berghe H. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet. Cytogenet. 1998; 101; 58 – 61.en_US
dc.identifier.citedreferencePerot C, Bougaran J, Boccon-Gibod L et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet. Cytogenet. 1999; 110; 54 – 56.en_US
dc.identifier.citedreferenceGarcia JA, Rini BI. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J. Clin. 2007; 57; 112 – 125.en_US
dc.identifier.citedreferenceTsuda M, Davis IJ, Argani P et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 2007; 67; 919 – 929.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2559.2008.03151.x.pdf
Size:
1.045MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.